Deal Flow
Letter · prints on one page
Transaction tear sheetData as of Nov 7, 2026
M&A · Healthcare · Buyer's industry: Surgical & Medical Instruments & Apparatus

Integra Lifesciences Holdings Corp to acquire Surgical Innovation Associates

Announced Dec 1, 2022 · Closed Dec 6, 2022 · Private target

Deal value$150M
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationNot disclosed

Transaction

Acquirer
Integra Lifesciences Holdings Corp (IART)
Target
Surgical Innovation Associates
Buyer type
Strategic
Offer price per share
—
Enterprise value
—
Status
Closed Dec 6, 2022

Deal protections

Not disclosed for private-company acquisitions.

Advisors

To the acquirer
Not disclosed
To the target
Not disclosed

Classification

Sector
Healthcare
Buyer's industry
Surgical & Medical Instruments & Apparatus
Sources
  • 8-K (EX-99.2) · Dec 1, 2022

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.